Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Conserved Binding Sites01:49

Conserved Binding Sites

4.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

11.2K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
11.2K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

9.3K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.3K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Caspases01:24

Caspases

12.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precise construction of nitrogen-containing nanohoop isomers: metal-induced modulation of nonlinear optical properties.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Novel Derivatives of Nucleoside, Diaryl Ether and Benzoquinone Isolated from the Marine-Derived Fungus <i>Aspergillus</i> sp. RCDB-W7.

ACS omega·2026
Same author

Structure-Based Design of a Highly Potent Dual-Competitive FTO Inhibitor for Targeted m<sup>6</sup>A Demethylase Inhibition in AML.

Journal of medicinal chemistry·2025
Same author

Mitochondrial ClpX Inhibition Induces Ferroptosis and Blocks Pancreatic Cancer Cell Proliferation.

Chembiochem : a European journal of chemical biology·2025
Same author

Applying natural product repurposing strategy to identify baicalein as novel caseinolytic protease P inhibitor and its application in the treatment of rice bacterial diseases.

Pesticide biochemistry and physiology·2025
Same author

Identification of RAPGEF3 as the therapeutic vulnerability of basal-subtype lung squamous cell carcinoma.

Oncogene·2025

Related Experiment Video

Updated: Aug 11, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K

Structural insights into the evolutionary simplification of human ClpP activators.

Lin-Lin Zhou1, Cai-Guang Yang2

  • 1State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Structure (London, England : 1993)
|February 3, 2023
PubMed
Summary

Researchers identified five novel ClpP agonists, named TRs, which show enhanced binding and increase proteolytic activity. These compounds effectively inhibit tumor cell growth, offering potential new cancer therapies.

More Related Videos

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.4K
Pulldown Assay Coupled with Co-Expression in Bacteria Cells as a Time-Efficient Tool for Testing Challenging Protein-Protein Interactions
07:03

Pulldown Assay Coupled with Co-Expression in Bacteria Cells as a Time-Efficient Tool for Testing Challenging Protein-Protein Interactions

Published on: December 23, 2022

3.0K

Related Experiment Videos

Last Updated: Aug 11, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.8K
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.4K
Pulldown Assay Coupled with Co-Expression in Bacteria Cells as a Time-Efficient Tool for Testing Challenging Protein-Protein Interactions
07:03

Pulldown Assay Coupled with Co-Expression in Bacteria Cells as a Time-Efficient Tool for Testing Challenging Protein-Protein Interactions

Published on: December 23, 2022

3.0K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • The ClpP protease is a validated target in oncology.
  • Developing potent and selective ClpP agonists is crucial for cancer therapy.

Purpose of the Study:

  • To characterize novel ClpP agonists with potential therapeutic applications.
  • To elucidate the structural basis for the interaction between these agonists and ClpP.

Main Methods:

  • Co-crystal structure determination of ClpP in complex with five novel agonists (TRs).
  • Biochemical assays to measure ClpP proteolytic activity.
  • In vitro studies assessing tumor cell growth inhibition.

Main Results:

  • Five novel ClpP agonists, designated TRs, were characterized.
  • Co-crystal structures revealed superior shape and charge complementarity compared to the known agonist ONC201.
  • The identified TRs significantly enhanced ClpP proteolytic activity.
  • These compounds demonstrated an inhibitory effect on tumor cell growth.

Conclusions:

  • The novel TR compounds represent promising therapeutic leads for cancer treatment.
  • Their enhanced interaction with ClpP suggests improved efficacy.
  • Further investigation into these agonists is warranted for drug development.